Publication

Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands

Jacobs, M. S., Schouten, J. F., de Boer, P. T., Hoffmann, M., Levin, L-Å. & Postma, M. J., 2018, In : Current Medical Research and Opinion. 34, 10, p. 1839-1847 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

DOI

Objective: There is limited evidence on patients' adherence and the impact of the prescribed dosing regimen in non-vitamin-K oral anticoagulants (NOACs). We aimed to assess secondary adherence to NOACs and to determine the impact of the dosing regimen in patients with atrial fibrillation.

Methods: Patients using a NOAC between 2009 and 2013 were identified from the nation-wide Swedish Prescribed Drug Register and the Dutch regional IADB.nl database. Patients using a consistent dosage for at least 180 consecutive days were included. Adherence was calculated using the medication possession ratio (MPR) and adjusted for overlapping dates. Adherence was defined as a MPR >= 0.8. Sensitivity analyses were performed using a MPR >= 0.9. Logistic regression was performed to compare secondary adherence and to explore the influence of the dosing regimen.

Results: A total of 5254 Swedish and 430 Dutch NOAC users were included. The mean MPR was 96.0% (SD 7.8%) in Sweden and 95.1% (SD 10.1%) in the Netherlands. Multivariable logistic regression analysis showed that a twice daily regimen had a lower likelihood of being secondary adherent compared to a once daily regimen in Sweden (odds ratio [OR] 0.21 [95% CI 0.12-0.35]).

Limitations: The influence of selection bias introduced by the inclusion criterion of >= 2 dispensations covering at least 180 days could not be excluded.

Conclusions: This study demonstrated that secondary adherence was high in this specific setting among patients with at least two initial dispensations of a NOAC covering a minimum of 180 days. The use of NOACs in a once daily regimen showed higher adherence compared to a twice daily regimen.

Original languageEnglish
Pages (from-to)1839-1847
Number of pages9
JournalCurrent Medical Research and Opinion
Volume34
Issue number10
Early online date30-Mar-2018
Publication statusPublished - 2018

    Keywords

  • Adherence, non-vitamin-K oral anticoagulants, anticoagulation, dosing regimen, apixaban, dabigatran, rivaroxaban, DAILY DOSING FREQUENCY, MEDICATION ADHERENCE, DABIGATRAN ADHERENCE, RISK FACTOR, WARFARIN, STROKE, IMPACT, PERSISTENCE, COHORT, RIVAROXABAN

View graph of relations

Download statistics

No data available

ID: 56320090